Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs.
Bartkowski M, Bincoletto V, Salaroglio IC, Ceccone G, Arenal R, Nervo S, Rolando B, Riganti C, Arpicco S, Giordani S. Bartkowski M, et al. Among authors: riganti c. J Colloid Interface Sci. 2024 Apr;659:339-354. doi: 10.1016/j.jcis.2023.12.166. Epub 2023 Dec 30. J Colloid Interface Sci. 2024. PMID: 38176243
Assessing gut barrier integrity and reproductive performance following pre-mating oral administration of solid-lipid-nanoparticles designed for drug delivery.
Lacconi V, Massimiani M, Antonello G, Gasco P, Bernardini R, Ferrari C, Ippoliti L, La Sala G, Pietroiusti A, Fenoglio I, Riganti C, Campagnolo L. Lacconi V, et al. Among authors: riganti c. Front Toxicol. 2025 Jan 7;6:1508598. doi: 10.3389/ftox.2024.1508598. eCollection 2024. Front Toxicol. 2025. PMID: 39839550 Free PMC article.
Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma.
Salaroglio IC, Aviles P, Kopecka J, Merlini A, Napoli F, Righi L, Novello S, Sullivan H, Cuevas C, Scagliotti GV, Riganti C. Salaroglio IC, et al. Among authors: riganti c. J Exp Clin Cancer Res. 2024 Dec 21;43(1):327. doi: 10.1186/s13046-024-03253-y. J Exp Clin Cancer Res. 2024. PMID: 39709435 Free PMC article.
Human and canine osteosarcoma cell lines: How do they react upon incubation with calcium phosphate-coated lipid nanoparticles carrying doxorubicin and curcumin?
Sapino S, Peira E, Chirio D, Chindamo G, Accomasso G, Vercelli C, Riganti C, Salaroglio IC, Gambino G, Re G, Amadori M, Gallarate M. Sapino S, et al. Among authors: riganti c. Int J Pharm. 2025 Jan 5;668:124970. doi: 10.1016/j.ijpharm.2024.124970. Epub 2024 Nov 19. Int J Pharm. 2025. PMID: 39566701 Free article.
First-In-Class Thiosemicarbazone Metal Complexes Targeting the Sigma-2 Receptor (S2R) as an Innovative Strategy against Pancreatic Cancer.
Barbanente A, Kopecka J, Vitone D, Niso M, Rizzi R, Cuocci C, Abatematteo FS, Mastropasqua F, Colabufo NA, Margiotta N, Arnesano F, Riganti C, Abate C. Barbanente A, et al. Among authors: riganti c. J Med Chem. 2024 Nov 28;67(22):20118-20134. doi: 10.1021/acs.jmedchem.4c01410. Epub 2024 Nov 17. J Med Chem. 2024. PMID: 39552021
298 results